Oh? Is he another department head who wants to destroy his department? Well, of course he is!
President Donald Trump has nominated Scott Gottlieb — a conservative pundit, physician and venture capitalist — to head the US Food and Drug Administration (FDA).
Gottlieb, who serves on the board of several pharmaceutical companies, is a vocal critic of the health-care reforms instituted by former president Barack Obama. At times, he has also characterized the FDA as standing in the way of innovation, slowing patients’ access to new drugs and limiting physicians’ autonomy.
The criticisms are based on experience: Gottlieb has worked at the agency before, including as deputy commissioner for medical and scientific affairs under former president George W. Bush. Gottlieb, who was nominated on 10 March, would have to be confirmed by the US Senate before taking office again.
If you read the rest of the article, and you should, you’ll learn that Gottlieb has plenty of conflicts of interest because he sits on the boards of companies that make the products he would regulate. To me, just as troubling, is that he is “a fellow of the American Enterprise Institute, a conservative think tank in Washington DC, where he has argued that some aspects of the Affordable Care Act, Obama’s signature health-care reform law, were predicated on misconceptions about US health-care economics.”
The AEI is very Ayn Rand-friendly. The invisible hand will fix things, but you know, some people will have to die before the market corrects itself. When Brand X (rhymes with “Lyson”) chickens are tainted and people drop dead after dinner, well, the Ol’ Market will correct itself because no one will buy them anymore, or when aspirin reaches $1K Ameros a pill, other manufacturers will rush to the market to make a killing. Except, you know, that business about protecting Intellectual Property which prevents other manufacturers from rushing to the market.